The Dubai Health Authority, DHA, has organised the 2nd Emirates International Conference in Radionuclide Therapy and Theransotics, starting on Friday.

The three-day medical event is managed by the Department of Nuclear Medicine and Molecular Imaging at the Dubai Hospital, part of the DHA.

The conference, the first of its kind in the Middle East, will discuss the treatment and diagnosis of cancer using radioactive nuclides. Its participants will include Gulf Cooperation Council, GCC, countries, as well as 10 other countries, including India, Pakistan, Sweden, Iran, Jordan, Iraq, Egypt, Nigeria, and Japan.

Batool Al Baloushi, Conference Chair, stated that the conference will discuss the latest trends and methods in the field of radionuclide therapy and molecular imaging, as well as the latest relevant research and protocols.

''The conference is unique because of the variety and the number of world-class lectures presented by experts in this field, to obtain the maximum benefits and exchange opinions and experiences,'' she added.

Fifteen international lecturers will participate in the conference and hold interactive sessions on radionuclide therapy for certain types of cancer, such as breast, thyroid and prostate cancers. The lecturers are all nuclear medicine professors from the UAE, Japan, the United States, Germany, Jordan, Kuwait, the Philippines and India.

During the conference, Prof. Jun Hatazawa, President of the Asian Federation of Nuclear Medicine, will present the latest therapy using boron neutron therapy for cancer, and highlight all nuclear medicine events in the region.